Skip to Content
Interactive Textbook on Clinical Symptom Research Logo


Home Button

Somatization and Symptoms Evaluation
Author Bios
Introduction
Defining Somatization
Detecting Symptoms
Dimensions of Symptoms
Measuring Symptoms
Currently selected section: Psychiatric Comorbidity
Interpreting Symptom Measures
Functional Syndromes and Symptoms
Etiology of Symptoms
Levels of Etiological Certainty
Strengthening Etiological Classification
Confounding Etiological Factors
Symptoms and Patient Expectations
Interpreting Patient Responses
Measuring Multiple Symptoms
Global Rating of Change
Measuring Somatization
Measuring Other Domains
Conclusions

 

Chapter 16: Somatization and Symptoms Evaluation: Psychiatric Comorbidity

        

 

You Answered:

Selection BFalse

Correct

The patient's PHQ-15 score of 17 puts her in the highest 10% of patients presenting in outpatient clinics and is a strong marker for somatization rather than a systemic medical disorder. Cutpoints of 5, 10, and 15 on the PHQ-15 represent mild, medium, and high levels of somatization respectively.

Somatization is typically defined as the tendency to experience and seek care for multiple, medically unexplained, physical symptoms. Although patients with either a multi-system disease or multiple chronic medical disorders (e.g. coronary artery disease, emphysema, osteoarthritis and diabetes mellitus) might experience numerous physical symptoms, they typically identify the small number of symptoms that are most bothersome rather than complete the PHQ-15 or any other symptom rating scale in such a "polysymptomatic" fashion as demonstrated in Figure 7.1.

At least 10% of patients presenting for medical care have high somatization scores, and another 20% have medium levels of somatization. Understanding the prevalence of medium to high symptom reporting in medical patients is important when interpreting the potential significance of disease-related symptoms, treatment side effects, or therapeutic responses in clinical or research settings. Separating somatizing tendencies inherent in certain individuals from symptoms due to extrinsic disorders, medications, or other agents may require baseline measures like the PHQ-15 as well as longitudinal assessment.

      Back to Question